0001127602-23-026945.txt : 20231107 0001127602-23-026945.hdr.sgml : 20231107 20231107160617 ACCESSION NUMBER: 0001127602-23-026945 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231103 FILED AS OF DATE: 20231107 DATE AS OF CHANGE: 20231107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jones John Jude CENTRAL INDEX KEY: 0001959460 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-05998 FILM NUMBER: 231383681 MAIL ADDRESS: STREET 1: 1166 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MARSH & MCLENNAN COMPANIES, INC. CENTRAL INDEX KEY: 0000062709 STANDARD INDUSTRIAL CLASSIFICATION: INSURANCE AGENTS BROKERS & SERVICES [6411] IRS NUMBER: 362668272 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1166 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 2123455000 MAIL ADDRESS: STREET 1: 1166 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: MARSH & MCLENNAN COMPANIES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: MARLENNAN CORP DATE OF NAME CHANGE: 19760505 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2023-11-03 0000062709 MARSH & MCLENNAN COMPANIES, INC. MMC 0001959460 Jones John Jude 1166 AVENUE OF THE AMERICAS NEW YORK NY 10036 1 Chief Marketing Officer 0 Common Stock 2023-11-03 4 M 0 4908 90.785 A 12886 D Common Stock 2023-11-03 4 S 0 4908 193.0831 D 7978 D Common Stock 1621.973 I MMC 401(k) Savings & Investment Plan Stock Options (Right to Buy) 90.785 2023-11-03 4 M 0 4908 0 D 2029-02-18 Common Stock 4908 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.001 to 193.15. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. These options were granted on February 19, 2019 and vested in four equal annual installments on February 19th of 2020, 2021, 2022 and 2023. /s/ Tessa Patti, Attorney-in-fact 2023-11-07